Mohamed Yousif

Dr. Mohamed Yousif

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2022 in Materials Research Express
Verified
Journal Article
Open access
HRHina Raza
Hina Raza
YIYusra Ilahi
Yusra Ilahi
ZRZermina Rashid
Zermina Rashid
SNShabnam Nazir
Shabnam Nazir
SMSuryyia Manzoor
Suryyia Manzoor
MYMohamed Yousif
Mohamed Yousif
Ceftriaxone is a third-generation cephalosporin antibiotic effective against many bacterial infections. However, owing to its instability in the gastrointestinal tract (GIT), it is administered by injections, which is an unfavourable route of administration. Therefore, the aim of this study was to formulate ceftriaxone into biodegradable and thermally stable polymeric blend microparticles that are suitable for oral delivery. The drug-loaded microparticles were prepared by the water-in-oil (W/O) emulsion method and consisted of starch and sodium alginate (NaAlg) as a polymeric matrix and glutaraldehyde (GA) as a cross-linking agent. Characterization of these particles using scanning electron microscopy (SEM) showed that the particles were spherical in shape with a smooth surface. Differential scanning calorimetry (DSC) and X-ray diffraction (XRD) of these particles showed no drug-polymer interactions. The highest percentage yield of particles was obtained at 3% polymer concentration. The particle size increased slightly after drug loading. The drug loading and entrapment efficiency appeared to increase with increasing polymer concentration. In vitro drug release at pH 1.2 and pH 7.4, revealed that drug release was below 20% at the acidic pH, while at pH 7.4, drug release of up to 85% was observed. The release mechanism followed first-order and Fickian diffusion patterns. Plasma concentration-time profiles were simulated for subcontinental Asian populations using commercial PBPK software, and the results suggest that microencapsulation of ceftriaxone sodium in a polymeric blend could represent a promising approach for controlled oral delivery of the drug, with enhanced absorption and bioavailability of the drug.

1 January 2026 in BioMed Research International
Verified
Journal Article
Open access
AKAqsa Khalid
Aqsa Khalid
RWRaheela Waheed
Raheela Waheed
ZRZermina Rashid
Zermina Rashid
FDFarah Deeba
Farah Deeba
AAAmbreen Aleem
Ambreen Aleem
MYMohamed Yousif
Mohamed Yousif
Infections are a cause of delayed wound healing, and the development of effective therapeutic strategies remains a key challenge. This study is aimed at developing and evaluating Zea mays leaf extract‐mediated zinc oxide nanoparticles (ZnZM NPs) for their antibacterial, antioxidant, and wound‐healing potential. Z . mays leaf extract was utilized for the green synthesis of ZnZM NPs, which were characterized using multiple analytical techniques. The UV‐visible spectrum exhibited a characteristic sharp absorption peak at 390 nm, and energy‐dispersive X‐ray (EDX) spectrometry confirmed the presence of zinc and oxygen. FT‐IR confirmed that the phytochemicals from Z . mays extract were involved in the reduction and capping of NPs. The ZnZM NPs were slightly aggregated, partially spherical, and crystalline, with an average crystallite size of 10.86 nm. The nanoparticles exhibited significant antibacterial activity against E. coli , P. aeruginosa , and K. pneumoniae . They also exhibited notable ferric ion‐reducing power and free radical‐scavenging ability. Topical gels containing 1% ZnZM NPs accelerated wound healing in rats compared with the control and standard (commercial product). Histopathological studies further confirmed enhanced tissue regeneration and accelerated wound healing in rats treated with NPs compared with the control and standard groups. Our findings suggest that biosynthesized zinc oxide nanoparticles possess antibacterial, antioxidant, and accelerated wound‐healing properties and can serve as an economic, safe, and sustainable nanomedicine for use in clinical settings.

11 November 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MYMohamed Yousif
Mohamed Yousif
Ilona KubajewskaIlona Kubajewska
Ilona Kubajewska
FMFatme Mawas
Fatme Mawas
SMSudaxshina Murdan
Sudaxshina Murdan
Background/Objectives: Sublingual vaccination offers a non-invasive route for inducing both systemic and mucosal immunity, yet the formulation properties that govern its success remain poorly defined. This study investigated the relationships among key formulation parameters for sublingual vaccines, such as viscosity, mucoadhesion, and mucosal residence, to understand their impact on in vivo immune responses in the sublingual delivery context. Methods: Ovalbumin (OVA)-based vaccine formulations containing cholera toxin B (CTB) adjuvant and mucoadhesive excipients such as hydroxypropyl methylcellulose (HPMC) or methylglycol chitosan (MGC), were evaluated for: (1) their respective rheological properties—characterized by viscosity and mucoadhesion parameters, as well as (2) in situ mucosal retention (assessed using Cy7-labeled formulations tracked by IVIS in vivo imaging system) and (3) in vivo immunogenicity via systemic (IgG) and mucosal (IgA) responses measured by ELISA, following sublingual administration to mice. Correlations between rheology, in situ/ex situ mucosal residence, and in vivo immune outcomes were determined. Results: Sublingual vaccine formulations containing HPMC exhibited the highest viscosity, mucoadhesion, and mucosal retention profiles, but paradoxically elicited the weakest systemic and mucosal antibody responses. In contrast, chitosan-based formulations enhanced immune responses even at reduced antigen and adjuvant doses, likely due to its permeation-enhancing and adjuvant effects. Correlation analyses revealed that while formulation viscosity and mucoadhesive strength were positively associated with mucosal retention, both rheological and retentive properties showed a significant inverse relationship with immunogenicity in the context of sublingual vaccine delivery. Conclusions: While viscosity and mucoadhesion are essential for in situ retention of sublingual vaccines, prolonged residence driven by excipient’s excessive rheological strength was found to reduce vaccine immunogenicity—likely due to restricted antigen release and mucosal uptake. Accordingly, HPMC appears suboptimal as a sublingual vaccine excipient, while chitosan shows promise for sublingual delivery as a permeation-enhancing adjuvant. These findings may shift the design paradigm for sublingual vaccine formulations, highlighting the need to balance mucosal retention with efficient antigen absorption for maximizing immune responses.

3 October 2024 in Journal of Oncology Pharmacy Practice
Verified
Journal Article
Open access
HRHina Raza
Hina Raza
MJMariyam Javaid
Mariyam Javaid
WRWajiha Rehman
Wajiha Rehman
SRSana Rafiq
Sana Rafiq
ZRZermina Rashid
Zermina Rashid
MYMohamed Yousif
Mohamed Yousif
Introduction: 5-Fluorouracil (5-FU) is a chemotherapeutic agent used to treat various types of cancers. Although widely used, it has consistently been attributed to cardiotoxicities after administration. The purpose of this study was to assess the parameters and predictors of cardiotoxicities associated with various 5-FU-based chemotherapeutic protocols in patients with GI/colorectal cancer, as well as the correlation of these cardiotoxic events with age, sex, cumulative dose, and risk factors such as obesity, hypertension, and family history of cardiac diseases. Methods: A prospective study consisting of 396 patients of both sexes was conducted in the oncology ward of Nishtar Hospital in Multan, Pakistan. Patients were grouped according to the therapeutic protocol they received (5-FU monotherapy or in combination, with different dosing regimens). Electrocardiography and serum troponin levels were used to assess 5-FU-induced cardiotoxicity. In cases where cardiotoxicity was detected, 5-FU treatment was interrupted; nitroglycerin, nitrates, and calcium channel blockers were administered; and cardiac monitoring was initiated. 5-FU was discontinued in all cases of acute myocardial infarction. Results: Of the 396 patients, 28.5% reported different cardiotoxic symptoms after receiving various 5-FU-containing protocols. 35% had anginal pain, 13% suffered a myocardial infarction, 11% developed hypertension, and 10% presented heart failure. Patients receiving 5-FU combination therapy showed cardiotoxic events that were significantly different from those on 5-FU monotherapy. Based on the ECG results, only the QTc-d interval increased significantly (p < 0.001) after therapy. 68% of the patients had troponin levels > 2 ng/mL at the end of treatment. Conclusions: Pre-existing cardiac diseases, treatment duration, smoking, and obesity were found to be influential components in the development of cardiotoxicity, and patients with cancer should be closely monitored during 5-FU chemotherapy.